This website uses cookies. By using this website, you agree to our Cookie Policy.
November 25, 2020
Intellectual Property partner John Moehringer comments on how the pandemic continues to disrupt scheduling for U.S. patent jury trials and suggests some future approaches that judges and lawyers may take to respond and adjust.